Tumour Models London returns for its 7th year while taking a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development.
The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient.
With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research.
The key questions at the heart of the Tumour Models Series:
Highlights from Tumour Models London 2017